CommercialCoverageMedium impact
New policies
Blue Cross Blue Shield of Rhode Island·RI · Oncology, Hematology, Pain Management +3 more·Physician / Facility
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has created two new medical policies effective January 1, 2026: Circulating Tumor-Tissue-Modified Viral DNA Testing for Cancer Management and Opioid Treatment Program. Billing teams must review the full policy text on BCBSRI.com for complete coverage and billing requirements.
Action Required
Before January 1, 2026: Billing team must access the Provider section of BCBSRI.com under Medical Policies heading to review full text of both new policies. Identify any prior authorization requirements, covered/non-covered services, and documentation requirements for circulating tumor DNA testing and opioid treatment programs. Update billing protocols and staff training accordingly.